RESUMEN
In United Lincolnshire NHS Hospitals Trust v CD and Guys and St Thomas' NHS Foundation Trust (GSTT) and South London and Maudsley NHS Foundation Trust (SLAM) v R, the Court of Protection was asked to make anticipatory and contingent declarations relating to the obstetric care and mode of delivery for currently capacitous women who were near to their due date but not yet in labour. In this case note I explore the judges' reasoning on the legal basis for these declarations. In so doing, I consider the wider implications of employing this seemingly new addition to the Court of Protection's armoury.
Asunto(s)
Toma de Decisiones , Parto Obstétrico/legislación & jurisprudencia , Parto Obstétrico/psicología , Rol Judicial , Competencia Mental/legislación & jurisprudencia , Trastornos Mentales/psicología , Mujeres Embarazadas/psicología , Femenino , Humanos , Programas Nacionales de Salud , Autonomía Personal , Embarazo , Reino UnidoRESUMEN
OBJECTIVE: Economic evaluation of a scientific advisory program with the Public Defenders Office to mitigate the impacts of the judicialization on health in the municipality, as well as the implementation of an active follow-up program to monitor health outcomes arising from court demands. METHODS: A two-step study, the first documental, retrospective, with data collection of lawsuits in the region of Barbalha (CE), Brazil, from 2013 to 2018, and the second stage, prospective and intervention, through mediation between the citizen and the Public Defenders Office, aiming to reduce the occurrence of the judicialization, and the monitoring of the health outcomes of the processes. The study adopted the Consolidated Health Economic Evaluation Reporting Standards protocol for economic health assessments. The data obtained from the processes were grouped and treated for characterization of the scenario. A comparison of the profile of the lawsuits in the period of 12 months before and after the installation of the program to delimit a complete fiscal cycle was carried out. RESULTS: The advisory service promoted a decrease of 40% (p=0.01) in lawsuits. There was a 31% reduction in court costs (p=0.003), with medicines accounting for 33% of this amount. There was a decrease in inputs outside the Sistema Único de Saúde lists (27%; p=0.003), however there was no statistical difference among several demanding groups, suggesting an equanimous approach. CONCLUSION: Data from the initial survey were comparable to those reported in Brazil regarding the profile of judicial demands. In view of the scenario, the proposal proved feasible as a means to mitigate the costs of the judicialization through mediation. Finally, the initiative can serve as a model for adoption by municipalities that have characteristics similar to those presented in this study.
Asunto(s)
Accesibilidad a los Servicios de Salud/legislación & jurisprudencia , Necesidades y Demandas de Servicios de Salud/legislación & jurisprudencia , Rol Judicial , Brasil , Ciudades , Costos de la Atención en Salud/legislación & jurisprudencia , Accesibilidad a los Servicios de Salud/economía , Necesidades y Demandas de Servicios de Salud/economía , Humanos , Programas Nacionales de Salud/legislación & jurisprudencia , Evaluación de Resultado en la Atención de Salud , Estudios Retrospectivos , Factores SocioeconómicosRESUMEN
OBJECTIVE: To analyze the legal demands of tiotropium bromide to treat chronic obstructive pulmonary disease. METHODS: We included secondary data from the pharmaceutical care management systems made available by the Paraná State Drug Center. RESULTS: Public interest civil action and ordinary procedures, among others, were the most common used by the patients to obtain the medicine. Two Health Centers in Paraná (Londrina and Umuarama) concentrated more than 50% of the actions. The most common specialty of physicians who prescribed (33.8%) was pulmonology. There is a small financial impact of tiotropium bromide on general costs with medicines of the Paraná State Drug Center. However, a significant individual financial impact was observed because one unit of the medicine represents 38% of the Brazilian minimum wage. CONCLUSION: Our study highlights the need of incorporating this medicine in the class of long-acting anticholinergic bronchodilator in the Brazilian public health system.
Asunto(s)
Broncodilatadores/economía , Medicamentos Esenciales/provisión & distribución , Necesidades y Demandas de Servicios de Salud/legislación & jurisprudencia , Rol Judicial , Enfermedad Pulmonar Obstructiva Crónica/economía , Bromuro de Tiotropio/economía , Brasil , Medicamentos Esenciales/economía , Accesibilidad a los Servicios de Salud/economía , Accesibilidad a los Servicios de Salud/legislación & jurisprudencia , Accesibilidad a los Servicios de Salud/tendencias , Necesidades y Demandas de Servicios de Salud/economía , Necesidades y Demandas de Servicios de Salud/tendencias , Humanos , Programas Nacionales de Salud , Enfermedad Pulmonar Obstructiva Crónica/tratamiento farmacológico , Estudios Retrospectivos , Estadísticas no Paramétricas , Factores de TiempoRESUMEN
ABSTRACT Objective To analyze the legal demands of tiotropium bromide to treat chronic obstructive pulmonary disease. Methods We included secondary data from the pharmaceutical care management systems made available by the Paraná State Drug Center. Results Public interest civil action and ordinary procedures, among others, were the most common used by the patients to obtain the medicine. Two Health Centers in Paraná (Londrina and Umuarama) concentrated more than 50% of the actions. The most common specialty of physicians who prescribed (33.8%) was pulmonology. There is a small financial impact of tiotropium bromide on general costs with medicines of the Paraná State Drug Center. However, a significant individual financial impact was observed because one unit of the medicine represents 38% of the Brazilian minimum wage. Conclusion Our study highlights the need of incorporating this medicine in the class of long-acting anticholinergic bronchodilator in the Brazilian public health system.
RESUMO Objetivo Analisar as demandas judiciais do brometo de tiotrópio para tratar a doença pulmonar obstrutiva crônica. Métodos Foram considerados dados secundários dos sistemas gerenciais de assistência farmacêutica, disponibilizados pelo Centro de Medicamentos do Paraná. Resultados Ações civis públicas e ações ordinárias, de procedimento comum, entre outras, foram as mais praticadas pelos pacientes para obter o medicamento. Duas Regionais de Saúde do Paraná (Londrina e Umuarama) concentraram mais de 50% das ações. Quanto à especialidade dos médicos prescritores, 33,8% eram pneumologistas. Verificou-se discreto impacto financeiro do brometo de tiotrópio nos gastos gerais com medicamentos pelo Centro de Medicamentos do Paraná. Entretanto, também houve relevante impacto financeiro individual, pois uma unidade do medicamento consome 38% do salário mínimo. Conclusão O estudo aponta para a necessidade de incorporação deste medicamento da classe broncodilatadores anticolinérgicos de longa duração, no Sistema Único de Saúde.
Asunto(s)
Humanos , Broncodilatadores/economía , Medicamentos Esenciales/provisión & distribución , Enfermedad Pulmonar Obstructiva Crónica/economía , Rol Judicial , Bromuro de Tiotropio/economía , Necesidades y Demandas de Servicios de Salud/legislación & jurisprudencia , Factores de Tiempo , Brasil , Estudios Retrospectivos , Estadísticas no Paramétricas , Medicamentos Esenciales/economía , Enfermedad Pulmonar Obstructiva Crónica/tratamiento farmacológico , Accesibilidad a los Servicios de Salud/economía , Accesibilidad a los Servicios de Salud/legislación & jurisprudencia , Accesibilidad a los Servicios de Salud/tendencias , Necesidades y Demandas de Servicios de Salud/economía , Necesidades y Demandas de Servicios de Salud/tendencias , Programas Nacionales de SaludRESUMEN
ABSTRACT Objective: Economic evaluation of a scientific advisory program with the Public Defenders Office to mitigate the impacts of the judicialization on health in the municipality, as well as the implementation of an active follow-up program to monitor health outcomes arising from court demands. Methods: A two-step study, the first documental, retrospective, with data collection of lawsuits in the region of Barbalha (CE), Brazil, from 2013 to 2018, and the second stage, prospective and intervention, through mediation between the citizen and the Public Defenders Office, aiming to reduce the occurrence of the judicialization, and the monitoring of the health outcomes of the processes. The study adopted the Consolidated Health Economic Evaluation Reporting Standards protocol for economic health assessments. The data obtained from the processes were grouped and treated for characterization of the scenario. A comparison of the profile of the lawsuits in the period of 12 months before and after the installation of the program to delimit a complete fiscal cycle was carried out. Results: The advisory service promoted a decrease of 40% (p=0.01) in lawsuits. There was a 31% reduction in court costs (p=0.003), with medicines accounting for 33% of this amount. There was a decrease in inputs outside the Sistema Único de Saúde lists (27%; p=0.003), however there was no statistical difference among several demanding groups, suggesting an equanimous approach. Conclusion: Data from the initial survey were comparable to those reported in Brazil regarding the profile of judicial demands. In view of the scenario, the proposal proved feasible as a means to mitigate the costs of the judicialization through mediation. Finally, the initiative can serve as a model for adoption by municipalities that have characteristics similar to those presented in this study.
RESUMO Objetivo: Avaliação econômica de um programa de aconselhamento científico junto à defensoria pública para minimizar o impacto da judicialização da saúde no município, bem como da implementação de um programa de pesquisa ativa para monitorar os desfechos em saúde provenientes de demandas judiciais. Métodos: Estudo conduzido em duas etapas. A primeira foi documental, retrospectiva, e composta por dados coletados de processos judiciais de 2013 a 2018 da região de Barbalha, no estado do Ceará. A segunda etapa foi prospectiva e de intervenção, conduzida por meio da mediação entre o cidadão e a defensoria pública, com o objetivo de reduzir a ocorrência da judicialização e monitorar os resultados dos processos de saúde. O estudo adotou o protocolo para avaliações econômicas em saúde Roteiro para Relato de Estudos de Avaliação Econômica. Os dados obtidos foram agrupados e tratados para caracterização do cenário. Comparou-se o perfil dos processos no período de 12 meses antes e após a instalação do programa para delimitar ciclo fiscal completo. Resultados: O serviço de consultoria promoveu redução de 40% (p=0,01) nas ações judiciais. Além disso, observou-se redução de 31% nos custos judiciais (p=0,003) com a medicação sendo responsável por 33% desse valor. Observou-se redução no uso de insumos não constantes nas listas do Sistema Único de Saúde (27%; p=0,003), contudo, sem diferença estatística entre os grupos. Conclusão: Os dados desta pesquisa foram comparáveis aos já relatados em pesquisas brasileiras quanto ao perfil de demandas. A proposta mostrou-se viável como meio de mitigar os custos da judicialização por meio da mediação. Essa iniciativa pode servir como modelo para os municípios que possuem características similares às apresentadas em nosso estudo.
Asunto(s)
Humanos , Rol Judicial , Accesibilidad a los Servicios de Salud/legislación & jurisprudencia , Necesidades y Demandas de Servicios de Salud/legislación & jurisprudencia , Factores Socioeconómicos , Brasil , Estudios Retrospectivos , Ciudades , Evaluación de Resultado en la Atención de Salud , Costos de la Atención en Salud/legislación & jurisprudencia , Accesibilidad a los Servicios de Salud/economía , Necesidades y Demandas de Servicios de Salud/economía , Programas Nacionales de Salud/legislación & jurisprudenciaRESUMEN
Alfie Evans was a terminally ill British child whose parents, clinging to hope, were desperately trying to save his life. Hospital authorities disagreed and petitioned the court to enjoin the parents from removing him and taking him elsewhere for treatment. The court stepped in and compelled the hospital to discontinue life support and claimed that further treatment was not in the child's best interest. This note discusses the heartbreaking stories of Alfie and two other children whose parents' medical decisions on their behalf were overridden by the court. It argues that courts should never decide that death is in a child's best interest and compel parents to withdraw life support from their children. Such a decision is outside the scope of the judiciary. Furthermore, it argues that even in those instances when the court may or must intervene, a new framework is necessary because the current framework used by the court to determine the best interest of the child ignores fundamental realities of child psychology. Too often, as a result of the court's mistaken framework, the court illegitimately trespasses into the parental domain. By adopting a new framework, the court will intervene only when actual abuse or neglect is suspected. In all other cases, judicial restraint will be practiced and the court will show greater deference to the parents' wishes.
Asunto(s)
Toma de Decisiones , Disentimientos y Disputas , Rol Judicial , Padres , Adolescente , Adulto , Terapias Complementarias/ética , Terapias Complementarias/legislación & jurisprudencia , Ética Institucional , Ética Médica , Femenino , Humanos , Identificación Psicológica , Lactante , Cuidados para Prolongación de la Vida/ética , Cuidados para Prolongación de la Vida/legislación & jurisprudencia , Masculino , Obligaciones Morales , Autonomía Personal , Autonomía ProfesionalRESUMEN
Juvenile drug treatment courts (JDTCs) were established in the 1990s to reduce the cycle of crime, drug use, and delinquency among youthful offenders. The principles and guidelines underlying JDTCs, roles of multidisciplinary team members, and procedures common to JDTCs are described. Youth served by JDTCs are frequently male, identify as racial or ethnic minorities, come from impoverished backgrounds, and experience significant psychiatric comorbidity. This article reviews the small number of clinical trials that have examined adjunctive treatments using family-based and individual behavioral treatment approaches designed to improve the overall efficacy of JDTCs. Considerations for future research on JDTCs are described.
Asunto(s)
Rol Judicial , Delincuencia Juvenil/legislación & jurisprudencia , Trastornos Relacionados con Sustancias/terapia , Adolescente , Humanos , Delincuencia Juvenil/prevención & control , Delincuencia Juvenil/psicología , Delincuencia Juvenil/rehabilitación , Trastornos Relacionados con Sustancias/psicología , Estados UnidosRESUMEN
Diabetic events occurring during court hearings previously required emergency medical services (EMS) transport to the emergency department (ED). A new process was implemented whereby the provincial court (PC) was notified by the detention center of diabetes status of prisoners scheduled for court later that day, enabling a community nursing services provider to provide on-site diabetes assessment and treatment at the PC. During the 13-month pre-implementation phase, there were 10 incidents of diabetic distress resulting in an ED visit at a total cost of $797.58/prisoner, including police service personnel, EMS, and ED staff/physician. During the 12.5-month postimplementation phase, insulin was administered on-site during 72 court dates at a cost of $161.93/prisoner. The new process for managing diabetic needs of prisoners during court dates resulted in a substantial cost savings in terms of police services and health care personnel and improved the immediacy and quality of care for prisoners.
Asunto(s)
Prestación Integrada de Atención de Salud/economía , Diabetes Mellitus , Servicio de Urgencia en Hospital/estadística & datos numéricos , Prisioneros , Adolescente , Adulto , Anciano , Ahorro de Costo , Femenino , Humanos , Rol Judicial , Masculino , Persona de Mediana Edad , Adulto JovenRESUMEN
OBJECTIVE: to develop juridical recommendations in order to avoid midwifery medical liability when providing intrapartum care. DESIGN: case law of the past 40 years concerning midwifery medical negligence when assisting labour/delivery in a hospital was analysed. Databases used were Jura and Judit (Belgium), Legifrance, Juricaf and Dalloz (France) and Recht, Rechtspraak (The Netherlands). A minority of cases were retrieved through contacts with insurance companies (only Belgium), lawyers and courts. SETTING: law suits in Belgium, France and The Netherlands. FINDINGS: the 100 analysed cases could be categorised into four types. The judicial assessment was focused on three domains of expertise of the midwife. Most cases involved interpreting fetal monitoring (47%), followed by recognising a specific pathology (32%) and responding to a complication (12%). A fourth type of case concerned exceeding the boundaries of the legal competencies of the midwife (9%). KEY CONCLUSIONS: not identifying fetal distress through fetal monitoring was the most common cause of midwifery liability (15/47), followed by not recognising the symptoms of a pathology (10/32), particularly placental abruption and uterine rupture. Also an inaccurate response to complications (3/12) and evidently exceeding the professional competencies involved midwifery liability. IMPLICATIONS FOR PRACTICE: achieving cardiotocograph interpretation skills is the first and most important recommendation. In pathologic cases, the midwife should immediately refer to an obstetrician, without any hesitation. The third recommendation is working in a team with the obstetrician. If the midwife has reasonable (evidence-based) doubts about the practice of the obstetrician, she should insist on re-assessment with respect to the boundaries of her competencies. The fourth recommendation concerns practising with knowledge of the client׳s/patient׳s medical record and updating the record with performances and observations. Consciously choosing the type of medical intervention in urgent cases of pathology is the final recommendation.
Asunto(s)
Parto Obstétrico/normas , Rol Judicial , Responsabilidad Legal , Partería/normas , Bélgica , Femenino , Sufrimiento Fetal/complicaciones , Sufrimiento Fetal/enfermería , Monitoreo Fetal , Francia , Humanos , Mala Praxis/legislación & jurisprudencia , Países Bajos , Embarazo , Complicaciones del Embarazo/diagnósticoRESUMEN
En Cataluña los Equipos de Atención Primaria Penitenciaria (EAPP) se han integrado en el Institut Català de la Salut (ICS). Esta integración facilitará la formación y actualización de los mismos, desaparecerán las diferencias existentes a nivel laboral entre servicios asistenciales pertenecientes a instituciones penitenciarias y los pertenecientes al Servei Català de la Salut. Permitirá el trabajo en equipo y la coordinación entre los EAP comunitarios y los (EAPP) de un mismo territorio compartiendo formación continuada, grupos de trabajo transversales y relación de base territorial, facilitando la continuidad asistencial y el abordaje integral e integrado de la cronicidad. Los sistemas de información existentes en Atención Primaria (AP) y la Historia clínica compartida de Cataluña son claves en este seguimiento. También se compartirán herramientas de soporte a la toma de decisiones clínicas, que contribuyen al aumento de calidad y seguridad clínica. Entre otras están las guías de práctica clínica electrónicas, guías terapéuticas, sistemas de alerta en prescripción, etc. Para los EAPP supondrá una oportunidad para introducirse en la docencia e investigación, que indirectamente repercutirá en la mejora de la calidad asistencial y de la formación de profesionales en este ámbito. La clave del éxito radicará en compartir un modelo único de atención a la cronicidad, donde se realicen actuaciones en promoción y prevención de la salud , seguimiento transversal de patologías y con la información asistencial compartida entre profesionales y niveles que a lo largo de la vida atiendan a la persona , este o no en el medio penitenciario (AU)
The Prison Primary Health Care Teams in Catalonia have been integrated into the Catalan Health Institute. This integration shall facilitate training and updating, while eliminating the existing differences between the health services belonging to prison institutions and those of the Catalan Health Service. It shall enable team work and coordination between Primary Health Care Teams in the community and the PHCTs in prisons within the same geographical area by sharing ongoing training, multi-sector work teams and territory-based relations, thereby facilitating continuance in care and complete and integrated treatment of chronicity. The existing information systems in Primary Health Care and the shared clinical history in Catalonia are key factors for this follow up process. Support tools for clinical decision making shall also be shared, which shall contribute towards an increase in quality and clinical safety. These tools include electronic clinical practice guides, therapeutic guides, prescription alert systems, etc. This shall be an opportunity for Prison Health Care Teams to engage in teaching and research, which in turn shall have an indirect effect on improvements in health care quality and the training of professionals in this sector. The critical factor for success is the fact that a unique chronicity health care model shall be shared, where measures for health promotion prevention can be taken, along with multi-sector monitoring of pathologies and with health care information shared between professionals and levels throughout the patients life, both in and out of the prison environment (AU)
Asunto(s)
Humanos , Masculino , Femenino , Rol del Médico/historia , Rol del Médico/psicología , Desempeño de Papel , Prisiones/legislación & jurisprudencia , Prisiones/organización & administración , Prevención Primaria/legislación & jurisprudencia , Prevención Primaria/métodos , Enfermedad Crónica/epidemiología , Enfermedad Crónica/psicología , Servicios de Salud/ética , Rol Profesional/psicología , Rol Judicial , Prisiones , Prisiones/normas , Atención Primaria de Salud/legislación & jurisprudencia , Atención Primaria de Salud/tendencias , Calidad de la Atención de Salud/ética , Calidad de la Atención de Salud/legislación & jurisprudencia , Servicios de Salud/legislación & jurisprudenciaRESUMEN
Conscientious Objection or conscientious refusal (CO) in access to reproductive health care is at the center of current legal debates worldwide. In countries such as the US and the UK, constitutional dilemmas surrounding CO in the context of reproductive health services reveal inadequate policy frameworks for balancing CO rights with women's rights to access contraception and abortion. The Colombian Constitutional Court's holistic jurisprudence regarding CO standards has applied international human rights norms so as to not only protect women's reproductive rights as fundamental rights, but to also introduce clear limits for the exercise of CO in health care settings. This paper reviews Latin American lines of regulation in Argentina, Uruguay, and Mexico City to argue that the Colombian Court's jurisprudence offers a strong guidance for future comprehensive policy approaches that aim to effectively balance tensions between CO and women's reproductive rights.
Asunto(s)
Negativa a Participar/legislación & jurisprudencia , Derechos Sexuales y Reproductivos/legislación & jurisprudencia , Aborto Legal/legislación & jurisprudencia , Argentina , Colombia , Femenino , Humanos , Rol Judicial , México , Embarazo , Salud Reproductiva/legislación & jurisprudencia , Servicios de Salud Reproductiva/legislación & jurisprudencia , UruguayRESUMEN
Legal actions have been playing a significant role as an alternative pathway to access to medicines in Brazil. These lawsuits demand medicines used in Primary Health Care as well as medicines that are still in clinical research and have not been market approved by the Brazilian National Agency for Sanitary Surveillance (ANVISA). The goal was to analyze medicines demanded through lawsuits brought to the judicial district which includes the city of Rio de Janeiro, Brazil, from July/2007 to June/2008. The medicines in 281 lawsuits were examined for their respective indications, classified according to their presence in publicly-funded lists, market approval by ANVISA, compliance with national clinical guidelines, existence of alternative therapies in lists and support of indication by scientific evidence. Six different categories were described, which are deemed useful to managers and the Judiciary in decision-making. The support of evidence is of utmost importance for medicines that are not included in public funding lists and also for those with no available therapeutic alternatives.
Demandas judiciais têm desempenhado um pa-pel importante como forma alternativa de aces-so a medicamentos no Brasil. Tais ações judiciais pleiteiam desde medicamentos usados na atenção básica até aqueles ainda em pesquisa clínica e sem registro no país pelo órgão sanitário local (Agência Nacional de Vigilância Sanitária - ANVISA). O objetivo foi analisar os medicamentos presentes nas demandas judiciais da Comarca da Capital do Rio de Janeiro, Brasil, no período de julho/2007 a junho/2008. Os medicamentos presentes em 281 ações judiciais foram examinados em relação à sua indicação terapêutica, e classificados de acordo com a presença em listas de financiamento público, a aprovação pela ANVISA, o cumprimento da indicação de diretrizes clínicas nacionais, a existência de terapias alternativas em listas de financiamento público e a existência de evidências científicas. Foram descritas, seis categorias diferentes, consideradas úteis para os gestores da saúde e do Judiciário no processo decisório. A busca de evidência científica é importante para os medicamentos que não estão incluídos nas listas e também para aqueles sem alternativas terapêuticas.
Las demandas han jugado un papel importante como una forma alternativa de acceso a los medicamentos en Brasil. Estas demandas incluyen los medicamentos utilizados en ensayos primarios, incluso los que continúan en investigación clínica y no están registrados en el país por la agencia de salud nacional (Agencia Nacional de Vigilancia Sanitaria - ANVISA). El objetivo fue analizar los fármacos presentes en las demandas de la región de Río de Janeiro durante el período de julio/2007 a junio/2008. Los fármacos presentes en 281 demandas fueron examinados por su indicación terapéutica, clasificados de acuerdo con su presencia en las listas de financiación pública, su aprobación por la ANVISA -lo que indica el cumplimiento de las directrices clínicas nacionales-, la existencia de terapias alternativas y la existencia de evidencias científicas. Se describieron seis categorías diferentes, en nuestra opinión, útiles para los gestores de la salud y la Justicia en el proceso de decisión. La búsqueda de evidencias científicas es importante para los medicamentos que no están incluidos en las listas, y también para los que no tienen alternativas terapéuticas.
Asunto(s)
Humanos , Toma de Decisiones , Medicamentos Esenciales/provisión & distribución , Medicina Basada en la Evidencia , Accesibilidad a los Servicios de Salud/legislación & jurisprudencia , Rol Judicial , Brasil , Política de Salud/legislación & jurisprudencia , Derechos del PacienteRESUMEN
Legal actions have been playing a significant role as an alternative pathway to access to medicines in Brazil. These lawsuits demand medicines used in Primary Health Care as well as medicines that are still in clinical research and have not been market approved by the Brazilian National Agency for Sanitary Surveillance (ANVISA). The goal was to analyze medicines demanded through lawsuits brought to the judicial district which includes the city of Rio de Janeiro, Brazil, from July/2007 to June/2008. The medicines in 281 lawsuits were examined for their respective indications, classified according to their presence in publicly-funded lists, market approval by ANVISA, compliance with national clinical guidelines, existence of alternative therapies in lists and support of indication by scientific evidence. Six different categories were described, which are deemed useful to managers and the Judiciary in decision-making. The support of evidence is of utmost importance for medicines that are not included in public funding lists and also for those with no available therapeutic alternatives.
Asunto(s)
Toma de Decisiones , Medicamentos Esenciales/provisión & distribución , Medicina Basada en la Evidencia , Accesibilidad a los Servicios de Salud/legislación & jurisprudencia , Rol Judicial , Brasil , Política de Salud/legislación & jurisprudencia , Humanos , Derechos del PacienteRESUMEN
OBJETIVO: Caracterizar os principais elementos processuais, médico-científicos e sanitários que respaldam as decisões das demandas judiciais individuais por medicamentos consideradas essenciais. MÉTODOS: Estudo descritivo retrospectivo com base em 27 ações julgadas em 2ª instância no Estado do Rio de Janeiro em 2006. Os processos originais foram solicitados ao Arquivo Central do Tribunal de Justiça do Estado do Rio de Janeiro, fotografados e analisados na íntegra. RESULTADOS: Todas as ações incluíram prescrição e atestado médicos. As prescrições estavam em desacordo com a legislação. Não houve perícia médica em nenhuma das ações e em 7,4 por cento constavam exames complementares. Apesar da escassa informação médica contida nos autos, todos os pedidos foram deferidos. CONCLUSÕES: O acolhimento de demandas judiciais carentes de subsídios clínicos e diagnósticos traz embaraços de ordem gerencial e sanitária ao sistema de saúde, pois comprometem a assistência farmacêutica regular e fomentam o uso irracional de medicamentos.
OBJECTIVE: To characterize the main medical, scientific and health-related procedural elements upon which decisions are made in individual lawsuits demanding medicines that are considered essential to the Court of Justice. METHODS: Retrospective descriptive study based on 27 cases ruled on by the Court of Appeals in Rio de Janeiro, Southeastern Brazil, in 2006. The original proceedings were solicited from the Central Archive of the Court of Justice of the State of Rio de Janeiro and were photographed and analyzed in full. RESULTS: Prescriptions and medical certificates were present in 100 percent of the lawsuits. All prescriptions lacked conformity to legislation. No expert medical reports were added, and only 7.4 percent of the lawsuits presented complementary examinations. In spite of the scarcity of medical information present in the records, all of the demands were granted. CONCLUSIONS: The admission of judicial demands devoid of clinical and diagnostic substantiation results in managerial and health-related constraints on the health system. Besides creating havoc in standard pharmaceutical services, badly justified medicine demands may compromise rational drug use.
OBJETIVO: Caracterizar los principales elementos procesales, medico-científicos y sanitarios que respaldan las decisiones de las demandas judiciales individuales por medicamentos consideradas esenciales. MÉTODOS: Estudio descriptivo retrospectivo con base en 27 acciones juzgadas en 2ª instancia en el estado de Rio de Janeiro, Sureste de Brasil, en 2006. Los procesos originales fueron solicitados al Archivo Central del Tribunal de Justicia del Estado de Rio de Janeiro, fotografiados y analizados de forma íntegra. RESULTADOS: Todas las acciones incluyeron prescripción y atestados médicos. Las prescripciones estaban en desacuerdo con la legislación. No hubo pericia médica en ninguna de las acciones y en 7,4 por ciento constaban exámenes complementarios. A pesar de la escasa información médica contenida en los autos, todos los pedidos fueron deferidos. CONCLUSIONES: El acogimiento de demandas judiciales carentes de subsidios clínicos y diagnósticos trae complicaciones de tipo gerencial y sanitaria al sistema de salud, ya que comprometen la asistencia farmacéutica regular y fomentan el uso irracional de medicamentos.
Asunto(s)
Humanos , Medicamentos Esenciales/provisión & distribución , Accesibilidad a los Servicios de Salud , Sistemas de Medicación , Brasil , Prescripciones de Medicamentos , Rol Judicial , Programas Nacionales de Salud , Derechos del Paciente , Sector Público , Estudios Retrospectivos , Factores de TiempoRESUMEN
OBJECTIVE: To characterize the main medical, scientific and health-related procedural elements upon which decisions are made in individual lawsuits demanding medicines that are considered essential to the Court of Justice. METHODS: Retrospective descriptive study based on 27 cases ruled on by the Court of Appeals in Rio de Janeiro, Southeastern Brazil, in 2006. The original proceedings were solicited from the Central Archive of the Court of Justice of the State of Rio de Janeiro and were photographed and analyzed in full. RESULTS: Prescriptions and medical certificates were present in 100% of the lawsuits. All prescriptions lacked conformity to legislation. No expert medical reports were added, and only 7.4% of the lawsuits presented complementary examinations. In spite of the scarcity of medical information present in the records, all of the demands were granted. CONCLUSIONS: The admission of judicial demands devoid of clinical and diagnostic substantiation results in managerial and health-related constraints on the health system. Besides creating havoc in standard pharmaceutical services, badly justified medicine demands may compromise rational drug use.
Asunto(s)
Medicamentos Esenciales/provisión & distribución , Accesibilidad a los Servicios de Salud/legislación & jurisprudencia , Sistemas de Medicación/legislación & jurisprudencia , Brasil , Prescripciones de Medicamentos , Humanos , Rol Judicial , Programas Nacionales de Salud , Derechos del Paciente/legislación & jurisprudencia , Sector Público , Estudios Retrospectivos , Factores de TiempoRESUMEN
During the Outreau case in France, 13 individuals were falsely accused of child sexual abuse and incarcerated. The author of this article testified as a psychiatric expert when the convictions were appealed. He explains how purposeful false statements by adults, inept expert witnesses, and the judicial assumption that children do not lie converged to create a tragic legal outcome. This article explains how psychiatric experts should conduct evaluations in cases of alleged child sexual abuse.
Asunto(s)
Abuso Sexual Infantil/legislación & jurisprudencia , Comparación Transcultural , Decepción , Incesto/legislación & jurisprudencia , Adulto , Niño , Abuso Sexual Infantil/psicología , Custodia del Niño/legislación & jurisprudencia , Preescolar , Conducta Cooperativa , Testimonio de Experto/legislación & jurisprudencia , Fantasía , Femenino , Cuidados en el Hogar de Adopción/legislación & jurisprudencia , Cuidados en el Hogar de Adopción/psicología , Francia , Homicidio/legislación & jurisprudencia , Homicidio/psicología , Humanos , Incesto/psicología , Rol Judicial , Masculino , Factores de Riesgo , Trastornos por Estrés Postraumático/diagnóstico , Trastornos por Estrés Postraumático/psicología , Sugestión , Revelación de la VerdadRESUMEN
OBJETIVO: Analisar o perfil dos requerentes e dos medicamentos pleiteados em ações judiciais. MÉTODOS: Estudo descritivo sobre 827 processos judiciais com 1.777 pedidos de medicamentos de 2005 a 2006 no Estado de Minas Gerais. Avaliaram-se os tipos de atendimento no sistema de saúde e a representação dos autores junto ao Poder Judiciário. Os medicamentos foram descritos segundo registro na Agência Nacional de Vigilância Sanitária, essencialidade, inclusão programática no Sistema Único de Saúde e evidências de eficácia. RESULTADOS: Mais de 70 por cento dos autores foram atendidos no sistema privado de saúde e 60,3 por cento foram representados por advogados particulares. O diagnóstico mais freqüente foi o de artrite reumatóide (23,1 por cento) e os imunossupressores foram os medicamentos mais solicitados (principalmente adalimumabe e etanercepte). Aproximadamente 5 por cento dos medicamentos pleiteados não eram registrados na Agência, 19,6 por cento estavam presentes na Relação Nacional de Medicamentos Essenciais, 24,3 por cento compunham o Programa de Medicamentos de Alto Custo e 53,9 por cento apresentavam evidência consistente de eficácia. Dentre os medicamentos não disponíveis no sistema público, 79,0 por cento apresentavam alternativa terapêutica nos programas de assistência farmacêutica. CONCLUSÕES: O fenômeno da judicialização na saúde pode indicar falhas do sistema público de saúde, uma vez que há solicitações de medicamentos constantes de suas listas. Todavia, constitui um obstáculo para a prática do uso racional de medicamentos e para a consolidação das premissas da Política Nacional de Medicamentos, principalmente quando são solicitados medicamentos sem comprovação de eficácia e não padronizados pelo Sistema Único de Saúde.
OBJECTIVE: To analyze the profile of claimants and medicines demanded in lawsuits. METHODS: Descriptive study that examined 827 lawsuits with 1,777 demands of access to medicines in the period between July 2005 and June 2006 in the state of Minas Gerais, Southeastern Brazil. There were examined the type of health care provided to claimants and their attorneyship. The medicines were described based on the following: drug registration at the National Health Surveillance Agency (Anvisa); wheter they were essential medicines; supply in the Brazilian Health System programs; and evidence of drug efficacy. RESULTS: More than 70 percent of the claimants were provided care in the private health system and 60.3 percent hired private lawyers. The most common diagnosis of claimants was rheumatoid arthritis (23.1 percent) and the immunosuppressant agents were the most frequent demand medicines (mainly adalimumab and etanercept). Approximately 5 percent of the medicines demanded were not registered at Anvisa, 19.6 percent were included in the Brazilian List of Essential Medicine, 24.3 percent were included in the High-Cost Drug Program and 53.9 percent showed consistent evidence of efficacy. Among the medicines that were not available in Brazilian Health System, 79.0 percent had therapeutic alternatives in drug programs. CONCLUSIONS: The phenomenon of judicialization of health in Brazil can point out failures in the public health system as some medicines demanded are included in its lists. However, it is a barrier for rational drug use and application of the National Drug Policy guidelines, especially when there are demanded medicines with no evidence of efficacy and that are not included in Brazilian Health System standards.
OBJETIVO: Analizar el perfil de los requirentes y de los medicamentos pleiteados en acciones judiciales. MÉTODOS: Estudio descriptivo sobre 827 procesos judiciales con 1.777 pedidos de medicamentos de 2005 a 2006 en el Estado de Minas Gerais, Sureste de Brasil. Se evaluaron los tipos de asistencia en el sistema de salud y la representación de los autores junto al Poder Judicial. Los medicamentos fueron descritos según registro en la Agencia Nacional de Vigilancia Sanitaria, esencialidad, inclusión programática en el Sistema Único de Salud y evidencias de eficiencia. RESULTADOS: Más de 70 por ciento de los autores fueron atendidos en el sistema privado de salud y 60,3 por ciento fueron representados por abogados particulares. El diagnóstico más frecuente fue el de artritis reumatoidea (23,1 por ciento) y los inmunosupresores fueron los más solicitados (principalmente adalimumabe y etanercepte). Aproximadamente 5 por ciento de los medicamentos pleiteados no eran registrados en la Agencia, 19,6 por ciento estaban presentes en la Relación Nacional de Medicamentos Esenciales, 24,3 por ciento componían el Programa de Medicamentos de Alto Costo y 53,9 por ciento presentaban evidencia consistente de eficiencia. Entre los medicamentos no disponibles en el sistema público, 79,0 por ciento presentaban alternativa terapéutica en los programas de asistencia farmacéutica. CONCLUSIONES: El fenómeno de la judicialización en la salud puede indicar fallas del sistema público de salud, dado que hay solicitudes de medicamentos constantes de sus listas. Aún constituye un obstáculo para la práctica del uso racional de medicamentos y para la consolidación de las premisas de la Política Nacional de Medicamentos, principalmente cuando son solicitados medicamentos sin comprobación de eficiencia y no estandarizados por el Sistema Único de Salud.
Asunto(s)
Adolescente , Adulto , Niño , Preescolar , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Medicamentos Esenciales/provisión & distribución , Accesibilidad a los Servicios de Salud , Decisiones Judiciales , Rol Judicial , Derechos del Paciente , Brasil , Política de Salud , Programas Nacionales de Salud , Sector PúblicoRESUMEN
The current adversarial tort-based system of adjudicating malpractice claims is flawed. Alternate methods of compensation for birth injuries related to oxygen deprivation or mechanical injury are being utilized in Virginia and Florida. Although utilization of both of these schemes is limited, and they are not without problems in application, both have been successful in reducing the number of malpractice claims in the tort system and in reducing malpractice premiums. While the Florida and Virginia programs are primarily focused on compensation, other models outside the US focus include compensation as well as enhanced dispute resolution and potential for clinical practice change through peer review. Experts in the fields of law and public policy in the United States have evaluated a variety of approaches and have proposed models for administrative health courts that would provide both compensation and dispute resolution for medical and nursing malpractice claims. These alternative models are based on transparency and disclosure, with just compensation for injuries, and opportunities for improvements in patient safety.
Asunto(s)
Traumatismos del Nacimiento/enfermería , Compensación y Reparación/legislación & jurisprudencia , Responsabilidad Legal , Mala Praxis/legislación & jurisprudencia , Enfermería Neonatal/legislación & jurisprudencia , Traumatismos del Nacimiento/economía , Femenino , Reforma de la Atención de Salud , Humanos , Recién Nacido , Rol Judicial , Masculino , Mala Praxis/economía , Administración de la Seguridad/legislación & jurisprudencia , Estados UnidosRESUMEN
OBJECTIVE: To analyze the profile of claimants and medicines demanded in lawsuits. METHODS: Descriptive study that examined 827 lawsuits with 1,777 demands of access to medicines in the period between July 2005 and June 2006 in the state of Minas Gerais, Southeastern Brazil. There were examined the type of health care provided to claimants and their attorneyship. The medicines were described based on the following: drug registration at the National Health Surveillance Agency (Anvisa); wheter they were essential medicines; supply in the Brazilian Health System programs; and evidence of drug efficacy. RESULTS: More than 70% of the claimants were provided care in the private health system and 60.3% hired private lawyers. The most common diagnosis of claimants was rheumatoid arthritis (23.1%) and the immunosuppressant agents were the most frequent demand medicines (mainly adalimumab and etanercept). Approximately 5% of the medicines demanded were not registered at Anvisa, 19.6% were included in the Brazilian List of Essential Medicine, 24.3% were included in the High-Cost Drug Program and 53.9% showed consistent evidence of efficacy. Among the medicines that were not available in Brazilian Health System, 79.0% had therapeutic alternatives in drug programs. CONCLUSIONS: The phenomenon of judicialization of health in Brazil can point out failures in the public health system as some medicines demanded are included in its lists. However, it is a barrier for rational drug use and application of the National Drug Policy guidelines, especially when there are demanded medicines with no evidence of efficacy and that are not included in Brazilian Health System standards.